Litcius/Paper detail

Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial

Jun Sato, Miyako Satouchi, Shoichi Itoh, Yusuke Okuma, Seiji Niho, Hidenori Mizugaki, Haruyasu Murakami, Yasuhito Fujisaka, Toshiyuki Kozuki, Kenichi Nakamura, Yukari Nagasaka, Mamiko Kawasaki, Tomoaki Yamada, Ryunosuke Machida, Aya Kuchiba, Yuichiro Ohe, Noboru Yamamoto

2020The Lancet Oncology210 citationsDOI

Topics & Concepts

MedicineLenvatinibInternal medicineThymic carcinomaOncologyAdverse effectClinical endpointResponse Evaluation Criteria in Solid TumorsCarcinomaClinical trialPhases of clinical researchChemotherapyCancerThyroid cancerMyasthenia Gravis and ThymomaVascular Malformations and HemangiomasGastrointestinal Tumor Research and Treatment